Skip to content

Patient-Reported Outcomes Among People Living with Chronic Pruritus

Patient-Reported Outcomes Among People Living with Chronic Pruritus (PROs-CP): A Single-Center, Multistage, Mixed-Methods Prospective Cohort Study in Thailand

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20240327001
Enrollment
500
Registered
2024-03-27
Start date
2024-03-20
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult patients aged 20 years or older with chronic pruritus (pruritus lasting six or more weeks) chronic pruritus disease burden health-related quality of life patient-reported outcomes psychometric properties

Interventions

All adult patients with chronic pruritus (itch lasting six or more weeks), regardless of skin manifestation in outpatient settings.
Treatment
Patients with chornic pruritus

Sponsors

Faculty of Medicine, Chiang Mai University
Lead Sponsor
Pharmacoepidemiology and Statistics Research Center (PESRC)
Collaborator

Eligibility

Sex/Gender
All
Age
20 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 20 years or older at the date of screening 2. Diagnosed with chronic pruritus based on the IFSI recommendation, itch lasting more than 6 weeks 3. Could read and communicate in the Thai language 4. Had an ability to understand and willingness to sign an informed consent statement and adhere to the study protocol

Exclusion criteria

Exclusion criteria: 1. Inability to answer questions or comply with the study protocol due to both physical and mental disability 2. Recent hospitalization within 3 months 3. Prognosis for survival is less than 12 months

Design outcomes

Primary

MeasureTime frame
Pruritus intensity every 3 month VAS, VRA, NRA,Itch symptoms every 3 month 5-D itch scale ,Patient global assessment of pruritus control every 3 months single item NRS of 0-10 points ,Chronic pruritus: disease control every 3 month multidimensional scale for assessing disease activity control ,Satisfaction with treatment care every 3 month single item NRS of 0-10 points ,Treatment satisfaction for chronic pruritus every 3 month multidimensional scale for capturing treatment satisfaction ,Health-Related Quality of Life every 3 month DLQI, EQ-5D-5L, Self-rated health-WHO, ItchyQoL, Global rating of change in HRQoL scale ,Mental Health and psychosocial Issues every 3 month PHQ-9, GAD-7, WHO-5 well-being index, BRCS, TAS-20, PUSH-D, RSES, UCLA loneliness scale-6,Psychosomatic Symptoms every 3 month ISI-7, SSS-8, Global Fatigue, Pain intensity, MAST

Secondary

MeasureTime frame
Blood Tests every 3 month Routine blood chemistry including, complete blood count, blood sugar, tests for electrolytes, liver/renal function test, lipid profile,Healthcare costs every 6 month direct costs (medical and non-medical costs), indirect costs,Hospitalization every year All-cause hospitalization,Mortality every year All-cause mortality

Countries

Thailand

Contacts

Public ContactSurapon Nochaiwong

Faculty of Pharmacy, Chiang Mai University

pesrc.pharmacy.cmu@gmail.com6653944342

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026